Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

1 day ago

NIH cuts delayed a cancer trial. Patients lost time they didn't have

1 day ago

Why we like Starbucks' latest turnaround move — plus, two more wins for Eli Lilly

1 day ago

Novo's new strategy hinges on something it can't manufacture: investor trust

2 days ago

Trump administration removes around 760,000 Obamacare enrollments

2 days ago

Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage

3 days ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo

5 days ago

Why more companies are fighting over beauty, health and wellness spending

5 days ago

Mitch McConnell returns to Senate after three-month health absence

11 days ago

Athletes with autism take center court at the US Open

12 days ago

Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy

12 days ago

Record U.S. cyclosporiasis outbreak is over, CDC says

15 days ago

A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now

15 days ago

Rare disease is taking his vision. A gene therapy could help — if he can get it

15 days ago

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

17 days ago

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

18 days ago

AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes

18 days ago

Pharma major Novartis falls 10% after three drug trial setbacks

18 days ago

Cholesterol drug setback casts doubt over multibillion-dollar race

18 days ago

Billionaire family offices back healthcare and biotech startups in August

23 days ago

Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge

24 days ago

We're adding 2 stocks to our Bullpen watchlist because they meet these criteria

24 days ago

This medical device stock looks like a gift for patient investors

24 days ago

August was the month of the comeback kids. Cramer reviews what drove the biggest winners

25 days ago

Trump strikes new drug pricing deals with nine midsized drugmakers

25 days ago

BioCryst is profitable. Now it wants to buy more rare disease drugs

29 days ago

How Taylor Farms became integral to America's food supply system

29 days ago

FDA approves daily HIV pill from Gilead designed to simplify treatment

29 days ago

HHS plans new FDA leadership roles for technology and drugs, sources say

29 days ago

Why vaccination rates are falling in the U.S.

1 month ago

BioMarin to acquire Alesta Therapeutics for $275 million

1 month ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

1 month ago